CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Coronary Protection to Prevent Coronary Obstruction During TAVR: A Multicenter International Registry Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve Replacement Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era Extracellular Myocardial Volume in Patients With Aortic Stenosis

Original ResearchApril 5, 2017 Vol 6, Issue 4

JOURNAL:J Am Heart Assoc. Article Link

Short Length of Stay After Elective Transfemoral Transcatheter Aortic Valve Replacement Is Not Associated With Increased Early or Late Readmission Risk

M Sud , F Qui, PC Austin et al. Keywords: TAVR; hospitalization; length of stay; readmission; transcutaneous aortic valve implantation

FULL TEXT PDF